News Image

Monday's session: gap up and gap down stocks

By Mill Chart

Last update: Jan 23, 2023

Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.

Today's gap up stocks

TickerChangeComment
JAGX7.0K%JAGUAR HEALTH INC (NASDAQ:JAGX) rose 7.0K% to $5.57 with a gap of 5.0K% during Monday's session. In the last 3 months the stock lost 41.59%.
SIEN779.0%SIENTRA INC's (NASDAQ:SIEN) stock price increased by 779.0% to $1.84 with a gap of 705.0%. The stock is trading 29.03% lower than 3 months ago.
OCSL199.0%OAKTREE SPECIALTY LENDING CO's (NASDAQ:OCSL) shares rose 199.0% to $21.02 with a gap of 196.0% during Monday's session.
VERB90.99%VERB TECHNOLOGY CO INC's (NASDAQ:VERB) stock price is advancing with 90.99% to a price of $0.44 with a gap of 36.71%. In the last month the stock gained 101.0%.
PLRX56.78%PLIANT THERAPEUTICS INC's (NASDAQ:PLRX) stock price is advancing with 56.78% to a price of $35.29 with a gap of 44.69%. Yesterday the company had a press release: Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis.
BOXD41.67%BOXED INC (NYSE:BOXD) rose 41.67% to $0.67 with a gap of 13.25% during Monday's session. In the last month the share price increased with 131.0%.
W25.09%WAYFAIR INC- CLASS A's (NYSE:W) shares rose 25.09% to $58.53 with a gap of 8.87%. Shareholders saw the stock price going 36.02% higher in the past month.
ALLR18.2%ALLARITY THERAPEUTICS INC's (NASDAQ:ALLR) shares rose 18.2% to $0.3 with a gap of 8.22% during Monday's session. In the last 3 months the stock lost 65.7%.
DBGI14.79%DIGITAL BRANDS GROUP INC's (NASDAQ:DBGI) stock price is advancing with 14.79% to a price of $2.95 with a gap of 3.31%. Shareholders saw the stock price going 30.73% lower in the past month.
POL.W14.29%1847 GOEDEKER INC -CW26's (NYSEARCA:POL.W) shares rose 14.29% to $0.08 with a gap of 13.96%. In the last 3 months the stock lost 22.11%.

To see the full list of gap up stocks you can use our gap up stocks screener.

Top gap down stocks

TickerChangeComment
NOGNW-36.3%SOFTWARE ACQ GROUP III -CW27's (NASDAQ:NOGNW) shares fell 36.3% to $0.04 with a gap of 49.29%. In the last month the stock gained 168.0%.
CPRX-26.83%CATALYST PHARMACEUTICALS INC's (NASDAQ:CPRX) shares fell 26.83% to $15.22 during Monday's session with a gap of 35.63%. Earlier today the company had a press release: Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®.
AMST-18.77%AMESITE INC's (NASDAQ:AMST) stock price is declining with 18.77% to a price of $0.23 with a gap of 57.02%. The stock is trading 28.31% higher than 3 months ago.
DRTT-15.15%DIRTT ENVIRONMENTAL SOLUTION's (NASDAQ:DRTT) shares fell 15.15% to $0.84 during Monday's session with a gap of 24.3%. In the last month the share price increased with 199.0%.
TCDA-13.83%TRICIDA INC's (NASDAQ:TCDA) stock price is declining with 13.83% to a price of $0.1 with a gap of 22.21%. The stock is trading 27.97% lower than a month ago.
RVYL-12.3%RYVYL INC's (NASDAQ:RVYL) stock price decreased by 12.3% to $0.72 with a gap of 16.28%. In the last month the stock gained 67.66%.
NXL-12.21%NEXALIN TECHNOLOGY INC's (NASDAQ:NXL) shares fell 12.21% to $1.0 with a gap of 14.39%. Shareholders saw the stock price going 38.91% higher in the past month.
AMV-11.78%ATLIS MOTOR VEHICLES I- CL A's (NASDAQ:AMV) shares fell 11.78% to $4.0 during Monday's session with a gap of 16.32%. A press release (Atlis Motor Vehicles Battery Cell Output Increases 15x as Production Ramps to Meet Customer Demand) was released earlier today.
XYL-10.89%XYLEM INC's (NYSE:XYL) shares fell 10.89% to $98.18 with a gap of 11.73%. A press release (Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction) was released earlier today.
AKAN-10.71%AKANDA CORP's (NASDAQ:AKAN) shares fell 10.71% to $0.19 during Monday's session with a gap of 35.83%. Shareholders saw the stock price going 52.5% higher in the past month.

To see the full list of gap down stocks you can use our gap down stocks screener.

Back

CATALYST PHARMACEUTICALS INC

NASDAQ:CPRX (3/28/2024, 8:03:20 PM)

After market: 15.9 -0.04 (-0.25%)

15.94

-0.33 (-2.03%)

CPRX News

News Image18 hours ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
News Image18 hours ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (

News Image2 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
News Image2 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (

News Image2 days ago - InvestorPlace3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List

Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.

News Image10 days ago - InvestorPlace7 Biotech Stocks Ready to Ride the Sector’s Resurgence

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

News Image10 days ago - Investor's Business DailyMadrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark

On Monday, Madrigal Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating jump to 83 from 69 a day ago.

News Image16 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
News Image16 days ago - Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile ...

News Image18 days ago - InvestorPlace3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio

While small-cap stocks can be incredibly risky, they also offer the potential for dramatic gains you won’t find with the big dogs.

News Image23 days ago - Investor's Business DailyAmicus Therapeutics Stock Sees RS Rating Improve To 74

In a welcome move, Amicus Therapeutics stock saw its Relative Strength Rating rise from 69 to 74 on Tuesday.

News Image24 days ago - The Motley Fool3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

CPRX Links
Follow us for more